Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040505 | SCV000064196 | likely benign | not specified | 2012-04-18 | criteria provided, single submitter | clinical testing | Pro19592Pro in Exon 265 of TTN: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence and it has been identified in 1/6572 European Am erican chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS;). Pro19592Pro in Exon 265 of TTN (allele fr equency = 0.01%, 1/6572) ** |
Labcorp Genetics |
RCV000559641 | SCV000643545 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-06-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001546599 | SCV001766141 | likely benign | not provided | 2020-02-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002371841 | SCV002623753 | likely benign | Cardiovascular phenotype | 2020-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |